Innovative and market-leading generics & biosimilars firm needed a comprehensive strategic approach to commercializing the firm’s first US market entry with a proprietary neurology molecule leveraging novel reformulation and drug delivery technology
StraNexa collaborated with the firm’s team to develop a holistic strategic commercialization approach, along with major tactics. Our plan included
- Refining the client’s product development approach, along with targeted market development and pre-marketing activities
- Ensuring optimal differentiation and positioning within a large and competitive market
AN EFFECTIVE FOUNDATION FOR FUTURE LAUNCH PLANNING AND ACTIVITIES.